Stockholders' Equity

6 Months Ended

Apr. 30, 2025

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 9. Stockholders' Equity

Analysis of Changes in Accumulated Other Comprehensive Loss:

(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	37.8		—		(8.7)		29.1
Tax effect	—		—		2.1		2.1
Balance at April 30, 2024	$	(500.2)	$	(3.2)	$	80.8	$	(422.6)
Balance at October 31, 2024	$	(461.7)	$	(4.9)	$	44.9	$	(421.7)
Gross change in value	51.0		—		(28.5)		22.5
Tax effect	—		—		6.9		6.9
Balance at April 30, 2025	$	(410.7)	$	(4.9)	$	23.3	$	(392.3)

Share Repurchases

In March 2017, the authorization under the 2012 Share Repurchase Program was increased to $1.0 billion by the Company's Board of Directors. As of April 30, 2025, $215.8 million remains authorized for repurchase.

During the three and six months ended April 30, 2025, the Company repurchased 0.5 million shares of its common stock for $40.6 million, at a weighted average price of $75.60 per share. There were no share repurchases during the three and six months ended April 30, 2024.

Dividends    

In December 2023, the Company's Board of Directors decided to end the declaration of a semiannual dividend.